Clinical trials: Survival Analysis
Papillary Thyroid Carcinoma; Molecular Heterogeneity; Multi-model Analysis; Artificial Intelligence; Lymph Node Metastases; Disease-free Survival
AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma
This study involved a comprehensive analysis of 256 PTC patients from Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSMH) and 499 patients from The Cancer Genome Atlas.
- Trial name
- NCT06241092
- Where
- China
- Volunteers
- 256 people
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Medullary Carcinoma of Colon, Prognostic Factors
Medullary Colonic Carcinoma
Retrospective cohort of 10 cases of colonic adenocarcinoma of medullary type, operated between 2000 and 2020 at the University Hospital of Limoges. Collection of relevant data for this rare entity.
- Conditions
- Medullary Carcinoma of Colon, Prognostic Factors, Survival Analysis
- Trial name
- MEDCCR (NCT05184153)
- Where
- France
- Volunteers
- 10 people
- Sponsor
- University Hospital, Limoges
PCNSL, Survival Analysis
Prognosis Factors in Patients With Primary Central Nervous System Lymphoma
Primary central nervous system lymphoma (PCNSL) is a rare extranodal non-hodgkin's lymphoma confined to the central nervous system. It accounts for about 4% of all intracranial tumors and 4% to 6% of all non-Hodgkin's lymphomas .
- Trial name
- NCT05167630
- Testing
- prognostic marker
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Zhengzhou University